delgocitinib: Clinical Trials

3 trials of delgocitinib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Not yet recruiting 2, Recruiting 1

Follow delgocitinib: new trials by email Literature Review of delgocitinib trials Research Report on delgocitinib

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of Delgocitinib 20 mg/g Cream in Subjects With Frontal Fibrosing Alopecia (FFA)
Delgocitinib - Frontal Fibrosing Alopecia
Phase 2Not yet recruitingMaryanne Makredes Senna302026-09-102026-08-26
Topical JAK-Inhibition of Early-Stage CTCL
delgocitinib - Mycosis Fungoides, Cutaneous T-cell Lymphoma
Phase 2Not yet recruitingAarhus University Hospital152026-09-012026-08-26
Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris
Delgocitinib - Central Centrifugal Cicatricial Alopecia, Lichen Planopilaris
Phase 2RecruitingIcahn School of Medicine at Mount Sinai302026-05-192026-07-10

Conditions studied

Alopecia (1)  ·  Lichen Planus (1)  ·  Lymphoma, T-Cell, Cutaneous (1)  ·  Mycosis Fungoides (1)

Sponsors

Aarhus University Hospital (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Maryanne Makredes Senna (1)

Countries

United States (2)

Top investigators

Benjamin Ungar, MD (1)  ·  Elisabeth Linde Grove, MD (1)  ·  Rikke Bech, MD, PhD (1)

NIH funding

2025 (1)